嘉里建設(00683.HK)向花樣年(01777.HK)售成都物業及車位55%權益
嘉里建設(00683.HK)公布,以代價4,702萬元人民幣,向花樣年(01777.HK)出售持有成都雅頌居項目第一期及第二期項目的權益,涉及未售出車位1,195個及住宅單位1個。
是次出售的目標公司成都公司I及成都公司II,由公司持股55%,並由控股股東嘉里控股及公司副主席兼行政總裁郭孔華的關連公司長春產業分別持股20%及25%。
公司就持有的55%權益將收取所得款項淨額估計達2,580萬元人民幣,除稅後利潤約2,300萬港元。嘉里建設表示,交易可變現非核心物業之價值,並可回收資本以實現更高的增長前景及投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.